Literature DB >> 24726473

Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5.

Margaret J McMillin1, Anita E Beck2, Jessica X Chong1, Kathryn M Shively1, Kati J Buckingham1, Heidi I S Gildersleeve1, Mariana I Aracena3, Arthur S Aylsworth4, Pierre Bitoun5, John C Carey6, Carol L Clericuzio7, Yanick J Crow8, Cynthia J Curry9, Koenraad Devriendt10, David B Everman11, Alan Fryer12, Kate Gibson13, Maria Luisa Giovannucci Uzielli14, John M Graham15, Judith G Hall16, Jacqueline T Hecht17, Randall A Heidenreich7, Jane A Hurst18, Sarosh Irani19, Ingrid P C Krapels20, Jules G Leroy21, David Mowat22, Gordon T Plant23, Stephen P Robertson24, Elizabeth K Schorry25, Richard H Scott18, Laurie H Seaver26, Elliott Sherr27, Miranda Splitt28, Helen Stewart29, Constance Stumpel20, Sehime G Temel30, David D Weaver31, Margo Whiteford32, Marc S Williams33, Holly K Tabor34, Joshua D Smith35, Jay Shendure35, Deborah A Nickerson35, Michael J Bamshad36.   

Abstract

Gordon syndrome (GS), or distal arthrogryposis type 3, is a rare, autosomal-dominant disorder characterized by cleft palate and congenital contractures of the hands and feet. Exome sequencing of five GS-affected families identified mutations in piezo-type mechanosensitive ion channel component 2 (PIEZO2) in each family. Sanger sequencing revealed PIEZO2 mutations in five of seven additional families studied (for a total of 10/12 [83%] individuals), and nine families had an identical c.8057G>A (p.Arg2686His) mutation. The phenotype of GS overlaps with distal arthrogryposis type 5 (DA5) and Marden-Walker syndrome (MWS). Using molecular inversion probes for targeted sequencing to screen PIEZO2, we found mutations in 24/29 (82%) DA5-affected families and one of two MWS-affected families. The presence of cleft palate was significantly associated with c.8057G>A (Fisher's exact test, adjusted p value < 0.0001). Collectively, although GS, DA5, and MWS have traditionally been considered separate disorders, our findings indicate that they are etiologically related and perhaps represent variable expressivity of the same condition.
Copyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24726473      PMCID: PMC4067551          DOI: 10.1016/j.ajhg.2014.03.015

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  A family with distal arthrogryposis and cleft palate: possible overlap between Gordon syndrome and Aase-Smith syndrome.

Authors:  K Becker; M Splitt
Journal:  Clin Dysmorphol       Date:  2001-01       Impact factor: 0.816

2.  Occurrence of Dandy-Walker anomaly in a familial case of distal arthogryposis type IIB.

Authors:  R Pallotta; T Ehresmann; P Fusilli
Journal:  Am J Med Genet       Date:  2000-12-18

3.  Camptodactyly, cleft palate, and club foot (the Gordon syndrome). A report of a large pedigree.

Authors:  F Halal; F C Fraser
Journal:  J Med Genet       Date:  1979-04       Impact factor: 6.318

4.  Camptodactyly, cleft palate, and club foot. A syndrome showing the autosomal-dominant pattern of inheritance.

Authors:  H Gordon; D Davies; M Berman
Journal:  J Med Genet       Date:  1969-09       Impact factor: 6.318

5.  The Gordon syndrome.

Authors:  B Say; D H Barber; R C Thompson; L G Leichtman
Journal:  J Med Genet       Date:  1980-10       Impact factor: 6.318

6.  The Gordon syndrome: autosomal dominant cleft palate, camptodactyly, and club feet.

Authors:  M Robinow; G F Johnson
Journal:  Am J Med Genet       Date:  1981

7.  Spectrum of mutations that cause distal arthrogryposis types 1 and 2B.

Authors:  Anita E Beck; Margaret J McMillin; Heidi I S Gildersleeve; Phillip R Kezele; Kathryn M Shively; John C Carey; Michael Regnier; Michael J Bamshad
Journal:  Am J Med Genet A       Date:  2013-02-07       Impact factor: 2.802

8.  Distal arthrogryposis type IIB: unreported ophthalmic findings.

Authors:  Jayashree Sahni; Stephen B Kaye; Alan Fryer; Paul Hiscott; Roger C Bucknall
Journal:  Am J Med Genet A       Date:  2004-05-15       Impact factor: 2.802

Review 9.  The mechanical control of nervous system development.

Authors:  Kristian Franze
Journal:  Development       Date:  2013-08       Impact factor: 6.868

10.  Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis.

Authors:  Bertrand Coste; Gunnar Houge; Michael F Murray; Nathan Stitziel; Michael Bandell; Monica A Giovanni; Anthony Philippakis; Alexander Hoischen; Gunnar Riemer; Unni Steen; Vidar Martin Steen; Jayanti Mathur; James Cox; Matthew Lebo; Heidi Rehm; Scott T Weiss; John N Wood; Richard L Maas; Shamil R Sunyaev; Ardem Patapoutian
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

View more
  67 in total

1.  Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels.

Authors:  Amanda H Lewis; Alisa F Cui; Malcolm F McDonald; Jörg Grandl
Journal:  Cell Rep       Date:  2017-06-20       Impact factor: 9.423

Review 2.  Developmental biology of the meninges.

Authors:  Krishnakali Dasgupta; Juhee Jeong
Journal:  Genesis       Date:  2019-03-13       Impact factor: 2.487

3.  Mutations of GPR126 are responsible for severe arthrogryposis multiplex congenita.

Authors:  Gianina Ravenscroft; Flora Nolent; Sulekha Rajagopalan; Ana M Meireles; Kevin J Paavola; Dominique Gaillard; Elisabeth Alanio; Michael Buckland; Susan Arbuckle; Michael Krivanek; Jérome Maluenda; Stephen Pannell; Rebecca Gooding; Royston W Ong; Richard J Allcock; Ellaine D F Carvalho; Maria D F Carvalho; Fernando Kok; William S Talbot; Judith Melki; Nigel G Laing
Journal:  Am J Hum Genet       Date:  2015-05-21       Impact factor: 11.025

Review 4.  The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities.

Authors:  Jessica X Chong; Kati J Buckingham; Shalini N Jhangiani; Corinne Boehm; Nara Sobreira; Joshua D Smith; Tanya M Harrell; Margaret J McMillin; Wojciech Wiszniewski; Tomasz Gambin; Zeynep H Coban Akdemir; Kimberly Doheny; Alan F Scott; Dimitri Avramopoulos; Aravinda Chakravarti; Julie Hoover-Fong; Debra Mathews; P Dane Witmer; Hua Ling; Kurt Hetrick; Lee Watkins; Karynne E Patterson; Frederic Reinier; Elizabeth Blue; Donna Muzny; Martin Kircher; Kaya Bilguvar; Francesc López-Giráldez; V Reid Sutton; Holly K Tabor; Suzanne M Leal; Murat Gunel; Shrikant Mane; Richard A Gibbs; Eric Boerwinkle; Ada Hamosh; Jay Shendure; James R Lupski; Richard P Lifton; David Valle; Deborah A Nickerson; Michael J Bamshad
Journal:  Am J Hum Genet       Date:  2015-07-09       Impact factor: 11.025

5.  A genetic-phenotypic classification for syndromic micrognathia.

Authors:  Qiming Chen; Yan Zhao; Yifeng Qian; Chenpei Lu; Guofang Shen; Jiewen Dai
Journal:  J Hum Genet       Date:  2019-07-04       Impact factor: 3.172

Review 6.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

Review 7.  Piezo2 in Cutaneous and Proprioceptive Mechanotransduction in Vertebrates.

Authors:  E O Anderson; E R Schneider; S N Bagriantsev
Journal:  Curr Top Membr       Date:  2017-01-16       Impact factor: 3.049

8.  Cell-Type-Specific Splicing of Piezo2 Regulates Mechanotransduction.

Authors:  Marcin Szczot; Leah A Pogorzala; Hans Jürgen Solinski; Lynn Young; Philina Yee; Claire E Le Pichon; Alexander T Chesler; Mark A Hoon
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

9.  Investigating the structural dynamics of the PIEZO1 channel activation and inactivation by coarse-grained modeling.

Authors:  Wenjun Zheng; Frederick Sachs
Journal:  Proteins       Date:  2017-09-23

10.  Merkel cells and Meissner's corpuscles in human digital skin display Piezo2 immunoreactivity.

Authors:  Y García-Mesa; J García-Piqueras; B García; J Feito; R Cabo; J Cobo; J A Vega; O García-Suárez
Journal:  J Anat       Date:  2017-09-14       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.